This metabolite contains a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 somewhere around 50% from the guardian drug. Plasma concentrations of the metabolite are close to forty% of Those people noticed for sildenafil, so the metabolite accounts for about 20% of si